Surgical treatment of recurrent endometrial carcinoma
β Scribed by Elio Campagnutta; Giorgio Giorda; Giovanni De Piero; Francesco Sopracordevole; M. Caterina Visentin; Luca Martella; Carlo Scarabelli
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 95 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Surgery does not have a definite role in the treatment of patients with recurrent endometrial carcinoma, except for those with central pelvic recurrences. The authors describe their experience with surgery in patients with abdominal endometrial recurrences.
METHODS
Between 1988 and 2000, 75 patients with abdominal and pelvic endometrial recurrences underwent secondary rescue surgery. Patients were classified according to the presence or absence of residual tumor after surgery. Therapy after rescue surgery was undertaken at the discretion of the medical oncologist. The progressionβfree interval and overall survival were defined as the time from secondary rescue surgery to the specific event and were evaluated by the KaplanβMeier method and the logβrank test. A Cox proportional hazards regression model was used to compare survival with covariates.
RESULTS
Fiftyβsix patients (74.7%) underwent optimal debulking. Major surgical complications were observed in 23 patients (30.7%). Only 1 postoperative death was observed, although the mortality rate for surgical complications after the postoperative period was 8%. Patients who underwent optimal debulking had a significantly better cumulative survival rate compared with patients who had residual disease (36% vs. 0% at 60 months; P < 0.05). Residual disease, chemotherapy after rescue surgery, and central pelvisβvagina as the only site of recurrence were associated significantly with survival.
CONCLUSIONS
The authors found that this approach was very challenging in terms of the procedures involved, the incidence of major surgical complications, and the high mortality rate. It was useful in increasing overall survival, provided that patients were free of macroscopic disease. Careful selection of patients is needed to minimize mortality. Cancer 2004;100:89β96. Β© 2003 American Cancer Society.
π SIMILAR VOLUMES
Ninety-four squamous cell carcinomas of the oral cavity, treated on the author's service between 1969 and 1981, were evaluated. The series included squamous cell carcinomas of various intraoral sites excluding the lips and hard palate. Survical of 60 mo was 70% for stage I, 65% for stage 11, 45% for